Filing Details
- Accession Number:
- 0001567619-21-006887
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-24 18:11:10
- Reporting Period:
- 2021-03-22
- Accepted Time:
- 2021-03-24 18:11:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1628171 | Revolution Medicines Inc. | RVMD | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1584999 | A. Vincent Miller | C/O Revolution Medicines, Inc. 700 Saginaw Drive Redwood City CA 94063 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-03-22 | 3,200 | $4.73 | 23,333 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-03-22 | 3,200 | $49.00 | 20,133 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2021-03-22 | 1,600 | $0.00 | 1,600 | $4.73 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2021-03-22 | 1,600 | $0.00 | 1,600 | $4.73 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
16,397 | 2029-08-08 | No | 4 | M | Direct | |
12,785 | 2029-08-08 | No | 4 | M | Direct |
Footnotes
- Includes 1,808 Restricted Stock Units.
- The option is early exercisable. One twenty-fourth (1/24th) of the shares initially subject to the option will vest on each monthly anniversary measured from August 9, 2019 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the second anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
- The option is early exercisable. One twelfth (1/12th) of the shares initially subject to the option will vest on each monthly anniversary measured from September 27, 2019 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the first anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.